7f6y › Citations

Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants.

<div class='caption-title'>Interaction of SARS-CoV-2 RBD variants with neutralizing antibodies.</div>
Xu H, Wang B, Zhao TN, Liang ZT, Peng TB, Song XH, Wu JJ, Wang YC, Su XD
OpenAccess logo Cell Res 31 1126-1129 (2021)
Related entries: 7ejy, 7ejz, 7ek0, 7f6z

Cited: 8 times
EuropePMC logo PMID: 34480123

Reviews citing this publication (1)

  1. There is nothing exempt from the peril of mutation - The Omicron spike. Behl T, Kaur I, Sehgal A, Singh S, Sharma N, Anwer MK, Makeen HA, Albratty M, Alhazmi HA, Bhatia S, Bungau S. Biomed Pharmacother 148 112756 (2022)

Articles citing this publication (7)

  1. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor. Lupala CS, Ye Y, Chen H, Su XD, Liu H. Biochem Biophys Res Commun 590 34-41 (2022)
  2. Recurrent SARS-CoV-2 mutations in immunodeficient patients. Wilkinson SAJ, Richter A, Casey A, Osman H, Mirza JD, Stockton J, Quick J, Ratcliffe L, Sparks N, Cumley N, Poplawski R, Nicholls SN, Kele B, Harris K, Peacock TP, Loman NJ. Virus Evol 8 veac050 (2022)
  3. Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants. Moyo-Gwete T, Madzivhandila M, Mkhize NN, Kgagudi P, Ayres F, Lambson BE, Manamela NP, Richardson SI, Makhado Z, van der Mescht MA, de Beer Z, de Villiers TR, Burgers WA, Ntusi NAB, Rossouw T, Ueckermann V, Boswell MT, Moore PL. J Virol 96 e0055822 (2022)
  4. SARS-CoV-2 Epitopes following Infection and Vaccination Overlap Known Neutralizing Antibody Sites. Yang L, Liang T, Pierson LM, Wang H, Fletcher JK, Wang S, Bao D, Zhang L, Huang Z, Zheng W, Zhang X, Park H, Li Y, Robinson JE, Feehan AK, Lyon CJ, Cao J, Morici LA, Li C, Roy CJ, Yu X, Hu T. Research (Wash D C) 2022 9769803 (2022)
  5. Characterizing the dynamics of BCR repertoire from repeated influenza vaccination. Mai G, Zhang C, Lan C, Zhang J, Wang Y, Tang K, Tang J, Zeng J, Chen Y, Cheng P, Liu S, Long H, Wen Q, Li A, Liu X, Zhang R, Xu S, Liu L, Niu Y, Yang L, Wang Y, Yin D, Sun C, Chen YQ, Shen W, Zhang Z, Du X. Emerg Microbes Infect 12 2245931 (2023)
  6. Human antibody BD-218 has broad neutralizing activity against concerning variants of SARS-CoV-2. Wang B, Xu H, Liang ZT, Zhao TN, Zhang X, Peng TB, Wang YC, Su XD. Int J Biol Macromol 227 896-902 (2023)
  7. Pseudotyped virus infection of multiplexed ACE2 libraries reveals SARS-CoV-2 variant shifts in receptor usage. Shukla N, Roelle SM, Snell JC, DelSignore O, Bruchez AM, Matreyek KA. PLoS Pathog 20 e1012044 (2024)


Quick links